Abstract
A Study of Suboptimally Controlled Participants Previously Taking Oral Disease-Modifying Drugs (DMDs) for Relapsing Forms of Multiple Sclerosis (RMS)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have